Small cap wrap: Ocean Power Technologies, Nextech3D.ai, Custom Health, First Phosphate…

Actinogen Medical Ltd (ASX:ACW, OTC:ATGGF) has outlined the scientific rationale supporting its lead drug candidate Xanamem® (emestedastat) as a potential treatment for Alzheimer’s disease, with results from the company’s first pivotal clinical trial expected in November 2026.

The company presented an overview of Xanamem and its development program in a 12-minute podium presentation titled Advancing Oral Xanamem in Alzheimer’s Disease at the annual Bioshares Biotech Summit in Queenstown, New Zealand.

First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF, FRA:KD0, OTC:FPHOY) announced that it has finalized agreements for $4.84 million in non-repayable funding from the Government of Canada through Natural Resources Canada’s First and Last Mile Fund to support infrastructure development for its Bégin-Lamarche phosphate deposit in Quebec.

The funding includes approximately $3.07 million for a study focused on clean energy infrastructure, including the site selection, connection corridors, feasibility work and design of a 161-kilovolt transmission line and substations in the Saguenay-Lac-Saint-Jean region. The project will also include technical, cost, environmental and consultation work.

Ocean Power Technologies Inc (NYSE-A:OPTT) announced that it has been selected as one of six potential awardees under a $40 million multiple-award contract supporting the Naval Oceanographic Office (NAVOCEANO).

The firm-fixed-price, indefinite-delivery/indefinite-quantity contract will support high-resolution ocean-floor mapping using long-endurance unmanned surface vehicles.

Custom Health Holdings Inc (TSX:CHLT) will acquire Spencer Health Solutions Inc, maker of the spencer smart medication dispenser and in-home monitoring platform, in a deal worth up to US$25 million, the company said Wednesday.

Custom Health already deploys the spencer device as part of its medication management model. The acquisition brings the technology in-house, giving the company control of Spencer's product roadmap and engineering.

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) has signed a strategic partnership with F2B Services, LLC aimed at expanding revenue through LED display solutions, event technology services and AI-powered software offerings.

The deal brings together Nextech's software and AI capabilities with F2B's presence in the event, exhibition, corporate communications and experiential marketing sectors.

Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF, FRA:9SU0) has closed the final tranche of its non-brokered private placement, bringing total gross proceeds raised to $964,700.

The final tranche raised $75,000 through 750,000 units priced at $0.10 each. Each unit includes one common share and half a warrant.

Miivo AI (TSX-V:MIVO) has highlighted growth in users, recurring revenue and product offerings in the first half of 2026 following the launch of three AI products aimed at helping businesses automate functions including financial analysis, lead generation and customer insights.

The company said it acquired more than 3,000 users during the six-month period, while average subscriber time spent on its platform increased significantly. Miivo also said it has helped businesses increase sales and acquire new customers, while expanding its base of recurring-revenue customers.

Shares of London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) jumped 10% to 1.6p after it reported a rock chip sample grading 143.1 grams of gold per tonne from its Amonett-Frank project in Nevada, the highest grade returned so far across its US portfolio.

The main market-listed company, chaired by David Lenigas, has been building a gold exploration business alongside its bitcoin mining operations.

Gran Tierra Energy Inc (TSX:GTE, LSE:GTE, NYSE-A:GTE) shares leapt over 45% to a three-year high after the oil producer agreed to sell all its Colombian and Ecuadorian assets for $1.3 billion and reported a return to quarterly profit.

French oil and gas producer Maurel & Prom will acquire the South American business, which produces around 29,000 barrels of oil per day and holds 144 million barrels of proved and probable reserves.

1947 Oil & Gas is to join AIM this month, raising £50 million to fund the purchase of a Houston-based producer with interests in eleven shallow-water fields in the Gulf of Mexico.

The newly incorporated company will issue 500 million shares at 10p, giving it a market capitalisation of £65 million on admission.

Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF, FRA:RR1) has appointed James Beams as an executive director with immediate effect, as the London-listed company shifts from feasibility work towards building its two rare earth projects.

It was one of two senior appointments announced in an update on Wednesday.

BlinkLab Ltd (ASX:BB1, OTC:BKLBF, FRA:P41) has reported positive results from a European ADHD study, marking a major step toward expanding its smartphone-based diagnostic platform beyond autism.

The study achieved sensitivity of 82% and specificity of 83% in children aged six to 17, supporting further development of BlinkLab Dx2, an artificial intelligence model designed to identify digital neurobehavioural markers associated with attention-deficit/hyperactivity disorder.

Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) (Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF)) remains on track to begin a Phase II trial of HMBD-002 in the fourth quarter of 2026, according to Edison Investment Research, which has maintained its A$84.4 million valuation, equivalent to 5.5 cents per share.

Edison said preparations for the study continued to advance during the June quarter, with good manufacturing practice drug substance production completed and final drug product expected to be released in September.